582 related articles for article (PubMed ID: 11850349)
1. Understanding costs and cost-effectiveness in critical care: report from the second American Thoracic Society workshop on outcomes research.
Am J Respir Crit Care Med; 2002 Feb; 165(4):540-50. PubMed ID: 11850349
[TBL] [Abstract][Full Text] [Related]
2. When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature.
Talmor D; Shapiro N; Greenberg D; Stone PW; Neumann PJ
Crit Care Med; 2006 Nov; 34(11):2738-47. PubMed ID: 16957636
[TBL] [Abstract][Full Text] [Related]
3. Economic Evaluation of Telemedicine for Patients in ICUs.
Yoo BK; Kim M; Sasaki T; Melnikow J; Marcin JP
Crit Care Med; 2016 Feb; 44(2):265-74. PubMed ID: 26540398
[TBL] [Abstract][Full Text] [Related]
4. Approach to economic analysis in critical care.
Kyeremanteng K; Wan C; D'Egidio G; Neilipovitz D
J Crit Care; 2016 Dec; 36():92-96. PubMed ID: 27546754
[TBL] [Abstract][Full Text] [Related]
5. Economic evaluation of the prophylaxis for thromboembolism in critical care trial (E-PROTECT): study protocol for a randomized controlled trial.
Fowler RA; Mittmann N; Geerts WH; Heels-Ansdell D; Gould MK; Guyatt G; Krahn M; Finfer S; Pinto R; Chan B; Ormanidhi O; Arabi Y; Qushmaq I; Rocha MG; Dodek P; McIntyre L; Hall R; Ferguson ND; Mehta S; Marshall JC; Doig CJ; Muscedere J; Jacka MJ; Klinger JR; Vlahakis N; Orford N; Seppelt I; Skrobik YK; Sud S; Cade JF; Cooper J; Cook D; ;
Trials; 2014 Dec; 15():502. PubMed ID: 25528663
[TBL] [Abstract][Full Text] [Related]
6. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
7. Clinical and Economic Outcomes of Telemedicine Programs in the Intensive Care Unit: A Systematic Review and Meta-Analysis.
Chen J; Sun D; Yang W; Liu M; Zhang S; Peng J; Ren C
J Intensive Care Med; 2018 Jul; 33(7):383-393. PubMed ID: 28826282
[TBL] [Abstract][Full Text] [Related]
8. Good research practices for measuring drug costs in cost effectiveness analyses: issues and recommendations: the ISPOR Drug Cost Task Force report--Part I.
Hay JW; Smeeding J; Carroll NV; Drummond M; Garrison LP; Mansley EC; Mullins CD; Mycka JM; Seal B; Shi L
Value Health; 2010; 13(1):3-7. PubMed ID: 19874571
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness of recombinant human erythropoietin for reducing red blood cells transfusions in critically ill patients.
MacLaren R; Sullivan PW
Value Health; 2005; 8(2):105-16. PubMed ID: 15804319
[TBL] [Abstract][Full Text] [Related]
10. Understanding economic outcomes in critical care.
Kahn JM
Curr Opin Crit Care; 2006 Oct; 12(5):399-404. PubMed ID: 16943716
[TBL] [Abstract][Full Text] [Related]
11. Economics of end-of-life care in the intensive care unit.
Pronovost P; Angus DC
Crit Care Med; 2001 Feb; 29(2 Suppl):N46-51. PubMed ID: 11228573
[TBL] [Abstract][Full Text] [Related]
12. Cost analysis of Omega-3 supplementation in critically ill patients with sepsis.
Kyeremanteng K; Shen J; Thavorn K; Fernando SM; Herritt B; Chaudhuri D; Tanuseputro P
Clin Nutr ESPEN; 2018 Jun; 25():63-67. PubMed ID: 29779820
[TBL] [Abstract][Full Text] [Related]
13. Evaluating the Cost-Effectiveness of the ABCDE Bundle: Impact of Bundle Adherence on Inpatient and 1-Year Mortality and Costs of Care.
Collinsworth AW; Priest EL; Masica AL
Crit Care Med; 2020 Dec; 48(12):1752-1759. PubMed ID: 33003078
[TBL] [Abstract][Full Text] [Related]
14. Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients.
Heyland DK; Dhaliwal R; Drover JW; Gramlich L; Dodek P;
JPEN J Parenter Enteral Nutr; 2003; 27(5):355-73. PubMed ID: 12971736
[TBL] [Abstract][Full Text] [Related]
15. Hospital costs of out-of-hospital cardiac arrest patients treated in intensive care; a single centre evaluation using the national tariff-based system.
Petrie J; Easton S; Naik V; Lockie C; Brett SJ; Stümpfle R
BMJ Open; 2015 Apr; 5(4):e005797. PubMed ID: 25838503
[TBL] [Abstract][Full Text] [Related]
16. [Methods for cost-effectiveness evaluation of intensive care].
Heslet L; Andersen JS; Keiding H
Ugeskr Laeger; 2007 Feb; 169(8):721-4. PubMed ID: 17313927
[TBL] [Abstract][Full Text] [Related]
17. Retrospective pharmacoeconomic evaluation of dosing vecuronium by peripheral nerve stimulation versus standard clinical assessment in critically ill patients.
Zarowitz BJ; Rudis MI; Lai K; Petitta A; Lulek M
Pharmacotherapy; 1997; 17(2):327-32. PubMed ID: 9085324
[TBL] [Abstract][Full Text] [Related]
18. Economic aspects of severe sepsis: a review of intensive care unit costs, cost of illness and cost effectiveness of therapy.
Burchardi H; Schneider H
Pharmacoeconomics; 2004; 22(12):793-813. PubMed ID: 15294012
[TBL] [Abstract][Full Text] [Related]
19. Federal and nationwide intensive care units and healthcare costs: 1986-1992.
Halpern NA; Bettes L; Greenstein R
Crit Care Med; 1994 Dec; 22(12):2001-7. PubMed ID: 7988140
[TBL] [Abstract][Full Text] [Related]
20. Effects of a multifaceted intervention QI program to improve ICU performance.
Ersson A; Beckman A; Jarl J; Borell J
BMC Health Serv Res; 2018 Nov; 18(1):838. PubMed ID: 30404646
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
